CRAMS Industry

  • INR 40000
  • USD 700
Subscribe Now

Annual Review

Domestic CRAMS business: Drivers

India, with its low-cost manufacture and cheaper, skilled labour has evolved into a preferred location for global pharma companies. Apart from these various factors have worked to the advantage of the Indian CRAMS industry. This chapter encapsulates the major factors which stimulate the Indian CRAMS industry. It also covers the following points-

  • Indian CRAMS industry
  • Performance of Indian pharma industry
  • Other factors driving CRAMS growth

Impact Analysis

  • CRAMS growth rate moderates, but prospects remains intact…

    With branded drugs worth ~US$105bn going off-patent by FY20, global pharmaceutical companies are expected to enhance their allocations to R&D to incre.....

    + Know More

Healthcare Coverage

Related Reports

Get Alerts

To receive CARE Research publications and alerts.

Register Now >>